Results 1 to 10 of about 169,700 (260)

Immunomodulatory therapy in ENT practice

Медицинский совет, 2016
Area Moscow’s regional research clinical institute n.a. M.F. Vladimirskiy Abstract. The article analyzes the experience of application of the immunomodulator Polyoxidonium in patients with respiratory diseases.
D. M. Mustafaev, V. I. Egorov
doaj   +1 more source

Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy

Journal of Ophthalmic & Vision Research, 2020
Purpose: To determine the efficacy and safety of infliximab therapy in patients with HLA B-27-associated ocular inflammation resistant or intolerant to conventional immunomodulatory therapy.
Asima Bajwa, Arash Maleki, Abhishek R Payal, Adriana Fandiño, María Inés Menéndez Padrón, Marisa Walsh, C Stephen Foster   +6 more
doaj   +1 more source

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination

Frontiers in Medicine, 2023
ObjectivesThis study aimed to assess the duration of humoral responses after two doses of SARS-CoV-2 mRNA vaccines in patients with inflammatory joint diseases and IBD and booster vaccination compared with healthy controls.
Selma Tobudic, Elisabeth Simader, Thomas Deimel, Jennifer Straub, Felix Kartnig, Leonhard X. Heinz, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Lisa Schneider, Thomas Nothnagl, Helga Radner, Florian Winkler, Florian Winkler, Heinz Burgmann, Karin Stiasny, Gottfried Novacek, Walter Reinisch, Daniel Aletaha, Stefan Winkler, Stephan Blüml   +20 more
doaj   +1 more source

Case report: Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 with severe myocardial dysfunction. Is there any hope in immunotherapy?

Journal of Education, Health and Sport, 2023
Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) develops in a small percentage of children after COVID-19, however, it might cause severe myocardial dysfunction.
Julita Tokarek, Emilian Budny, Renata Szmigielska   +2 more
doaj   +1 more source

Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients

Frontiers in Oncology, 2021
BackgroundCereblon (CRBN) is a direct target of immunomodulatory drugs (IMiDs) and is known to be sensitive and responsive to IMiD therapy. We evaluated CRBN expression in bone marrow plasma cells and analyzed whether CRBN expression was associated with ...
Byung-Hyun Lee, Ka-Won Kang, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Yong Park, Chul Won Choi, Byung Soo Kim   +9 more
doaj   +1 more source

Identifying CNS infections in transplantation and immunomodulatory therapy [PDF]

Therapeutic Advances in Infectious Disease
Benjamin A Jones, Shruti Agnihotri, Kiran T Thakur   +2 more
exaly   +2 more sources

Influence of treatment in multiple sclerosis dysability: an open, retrospective, non-randomized long-term analysis Influência do tratamento na incapacidade da esclerose múltipla: estudo aberto, retrospectivo e não randomizado em longo prazo

Arquivos de Neuro-Psiquiatria, 2010
The efficacies of immunosuppressive (IMS) and immunomodulatory (IMM) drugs for multiple sclerosis (MS) have been reported in several studies. These agents can reduce relapse rates and lesions observed by magnetic resonance imaging studies.
Lineu Cesar Werneck, Paulo José Lorenzoni, Vitor A Radünz, Marco A.T Utiumi, Cláudia Suemi Kamoi Kay, Rosana Herminia Scola   +5 more
doaj   +1 more source

APPLICATION OF UMMUNOMODULATORY THERAPY IN THE COMPLEX OF RELAPSE THERAPY OF HPV-ASSOCIATED INVASIVE AND  MICROINVASIVE CERVICAL CANCER

Медицинский совет, 2017
Cervical cancer is one of the most common localized tumours of the female genital sphere. According to WHO, 16 710 new cases of cervical cancer were registered in Russia in 2015.
Y. E. Dobrokhotova, M. G. Venediktova, A. N. Sarantsev, K. V. Morozova, A. E. Zykov, A. S. Khasan, N. P. Panova, Y. A. Savina, V. A. Suvorova, K. F. Orudzhova   +9 more
doaj   +1 more source

New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease

Frontiers in Medicine, 2021
Uveitis associated with Vogt-Koyanagi-Harada (VKH) disease is a bilateral, chronic, granulomatous autoimmune disease associated with vitiligo, poliosis, alopecia, and meningeal and auditory manifestations.
Ahmed M. Abu El-Asrar, Ahmed M. Abu El-Asrar, Jo Van Damme, Sofie Struyf, Ghislain Opdenakker   +4 more
doaj   +1 more source

EFFICIENCY OF SOME IMMUNOMODULATORY DRUGS FOR PREVENTION OF RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS IN YOUNG SCHOOLCHILDREN WITH RECURRENT RESPIRATORY INFECTIONS

Медицинская иммунология, 2014
. We performed a study of efficiency for various immunocorrective drugs in a group of 548 young schoolchildren with recurrent respiratory infections. Frequency of respiratory infections and complication rates were taken as endpoints in this study. It was
R. V. Maiorov, M. V. Chereshneva, S. D. Verzilin, V. A. Chereshnev   +3 more
doaj   +1 more source